Bringing the latest Evidence-based Clinical Practices to US Physicians 		Home | Advisory Board | Contact | Help | Sitemap  
 
Advanced search 
Login to participate
Forgot password
Register here >>
 Clinical Cardiology
DVT Prophylaxis
Emergency Physicians
Interventional Cardiology
PE Prophylaxis
Pharmacists
Special Risk Populations
Surgery
VTE Treatment

Expert Commentary
Thrombosis Podcasts
Live Presentations
Case Studies
Slide Kits
Publications
Monographs
Symposia Highlights
Meeting Highlights
Latest News
Clinical Trials Corner
Registries Corner
CME Learning Center
CE Learning Center
Resource Room
Association Meetings
Advisory Board

About Us
Contact Us
  

 


Have you checked out the INATE website?
   
 




Content for site developed under the guidance of the TRACK Advisory Council.

You are here: Home / Expert Commentary /

  Antithrombotic Therapy Considerations in Special Patient Populations   Printer-friendly version
 
 

Biography
Go to biography

Antithrombotic Therapy Considerations in Special Patient Populations

A Two-part CME Program

Expert Commentary by Edith Nutescu, PharmD


 
_Antithrombotic Therapy Considerations in Special Patient Populations


  
ThrombosisClinic.com is supported by an educational grant from sanofi-aventis U.S. 
© 2008 Excerpta Medica, Inc. All rights reserved.


Terms and Conditions | Privacy Policy